140 related articles for article (PubMed ID: 2540562)
21. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
22. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
[No Abstract] [Full Text] [Related]
23. Total lymphoid irradiation (TLI) in the cyclosporine era--use of TLI in resistant cardiac allograft rejection.
Levin B; Bohannon L; Warvariv V; Bry W; Collins G
Transplant Proc; 1989 Feb; 21(1 Pt 2):1793-5. PubMed ID: 2652586
[No Abstract] [Full Text] [Related]
24. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor.
Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565
[No Abstract] [Full Text] [Related]
25. Monitoring of renal allografts under immunosuppression.
Hammer C
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110
[No Abstract] [Full Text] [Related]
26. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
27. Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir.
Nicholson ML; Veitch PS; Donnelly PK; Flower AJ; Bell PR
Transplant Proc; 1990 Aug; 22(4):1811-2. PubMed ID: 2167535
[No Abstract] [Full Text] [Related]
28. Total lymphoid irradiation.
Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
[TBL] [Abstract][Full Text] [Related]
29. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
O'Hair DP; Johnson CP; Roza AM; Adams MB
Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
[No Abstract] [Full Text] [Related]
30. [Rejections and cytomegalovirus infections after renal transplantation].
Bernheim J; Touraine JL; Berthoux FC; Blanc N; Traeger J
Sem Hop; 1976 Jun 9-16; 52(22-23):1361-5. PubMed ID: 183271
[TBL] [Abstract][Full Text] [Related]
31. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model.
Bruning JH; Bruggeman CA; van Boven CP; van Breda Vriesman PJ
Transplantation; 1986 Jun; 41(6):695-8. PubMed ID: 3012832
[TBL] [Abstract][Full Text] [Related]
32. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation.
Mills RA; Coster DJ; Williams KA
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):647-55. PubMed ID: 11867579
[TBL] [Abstract][Full Text] [Related]
33. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
[No Abstract] [Full Text] [Related]
34. Cytomegalovirus infection in allograft recipients.
Lancet; 1989 Feb; 1(8633):303-4. PubMed ID: 2563459
[No Abstract] [Full Text] [Related]
35. Cell-mediated immune responses in rat cytomegalovirus infection.
Esa AH; Vogelsang GB; Sandford GR; Saral R; Hess AD; Burns WH
Transplant Proc; 1987 Feb; 19(1 Pt 3):2726-9. PubMed ID: 3029923
[No Abstract] [Full Text] [Related]
36. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
37. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
[TBL] [Abstract][Full Text] [Related]
38. Renal allograft function and cytomegaly.
Jirka J; Horcicková M; Reneltová I; Rossmann P; Seeman J; Holá V; Kocandrle V
Proc Eur Dial Transplant Assoc; 1980; 17():407-12. PubMed ID: 6264421
[TBL] [Abstract][Full Text] [Related]
39. Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients.
Sonoda K; Meek AG; Strober S; Hayashi R; Ishimaru M; Rapaport FT
Transplant Proc; 1989 Feb; 21(1 Pt 1):1116-7. PubMed ID: 2650070
[No Abstract] [Full Text] [Related]
40. Management of immunosuppressive problems in renal allograft recipients.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
